These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9824932)

  • 21. Spontaneous neonatal chylothorax treated with octreotide.
    Siu SL; Lam DS
    J Paediatr Child Health; 2006; 42(1-2):65-7. PubMed ID: 16487393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
    Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
    Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative chylothorax after cardiothoracic surgery in children.
    Chan EH; Russell JL; Williams WG; Van Arsdell GS; Coles JG; McCrindle BW
    Ann Thorac Surg; 2005 Nov; 80(5):1864-70. PubMed ID: 16242470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enterocutaneous fistula: are treatments improving?
    Draus JM; Huss SA; Harty NJ; Cheadle WG; Larson GM
    Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Octreotide in bleeding caused by intestinal angiodysplasia].
    Lourdes Ruiz Rebollo M; Barrio Andrés J; Fernández-Orcajo P; Prada Lobato J; Mena Martín FJ; Velicia Llames R; Caro-Paton A
    Gastroenterol Hepatol; 2008 Dec; 31(10):713-4. PubMed ID: 19174089
    [No Abstract]   [Full Text] [Related]  

  • 26. Octreotide for paediatric sulfonylurea poisonings.
    Osterhoudt KC
    J Paediatr Child Health; 2009; 45(7-8):473. PubMed ID: 19712185
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe congenital chylothorax treated with octreotide.
    Young S; Dalgleish S; Eccleston A; Akierman A; McMillan D
    J Perinatol; 2004 Mar; 24(3):200-2. PubMed ID: 15044932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to use octreotide for malignant bowel obstruction.
    Ripamonti C; Mercadante S
    J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of octreotide in malignant bowel obstruction.
    Krammer LM
    Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
    [No Abstract]   [Full Text] [Related]  

  • 31. New Tools for Congenital Hyperinsulinism.
    Da Lozzo P; Risso FM; Schleef J; Sirchia F; Sagredini R; Bussani R; D'Adamo AP; Barbi E; Tornese G
    Clin Pediatr (Phila); 2021 Jul; 60(8):336-340. PubMed ID: 33971777
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide.
    Büyükyavuz I; Karnak I; Yiğit S; Tanyel FC
    Turk J Pediatr; 2004; 46(3):289-91. PubMed ID: 15503489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report.
    Sivasli E; Dogru D; Aslan AT; Yurdakok M; Tekinalp G
    J Perinatol; 2004 Apr; 24(4):261-2. PubMed ID: 15067298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case with intestinal lymphangiectasia successfully treated with slow-release octreotide.
    Filik L; Oguz P; Koksal A; Koklu S; Sahin B
    Dig Liver Dis; 2004 Oct; 36(10):687-90. PubMed ID: 15506669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes and management of postoperative enterocutaneous fistulas.
    Memon AS; Siddiqui FG
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):25-8. PubMed ID: 14764257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide for palliative treatment of bleeding from unresectable gastric cancer.
    Sanaka M; Yamamoto T; Kawakami T; Kuyama Y
    Hepatogastroenterology; 2005; 52(64):2 p preceding I. PubMed ID: 16001612
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report.
    Tamagno G; Mioni R; De Carlo E; Maffei P; Rubello D; Sicolo N
    Dig Liver Dis; 2004 Dec; 36(12):843-6. PubMed ID: 15646433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue.
    Murao S; Hirata K; Ishida T; Takahara J
    Endocr J; 1999 Jun; 46(3):477-8. PubMed ID: 10504003
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful treatment of repaglinide-induced hypoglycemia with octreotide.
    Fasano CJ; Rowden AK
    Am J Emerg Med; 2009 Jul; 27(6):756.e3-4. PubMed ID: 19751648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.